Abnormal level of leptin and dysregulation of leptin signaling have been identified to be crucial players in pathogenesis of HCC, contributing to the malignant development and progress of obesity-related liver cancer [6–8]. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.